Symbol="SLDB"
AssetType="Common Stock"
Name="Solid Biosciences LLC"
Description="Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1707502"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="74486000"
EBITDA="-103530000"
PERatio="None"
PEGRatio="None"
BookValue="9.39"
DividendPerShare="0"
DividendYield="0"
EPS="-7.96"
RevenuePerShareTTM="0.535"
ProfitMargin="0"
OperatingMarginTTM="-17.17"
ReturnOnAssetsTTM="-0.303"
ReturnOnEquityTTM="-0.491"
RevenueTTM="6169000"
GrossProfitTTM="13620000"
DilutedEPSTTM="-7.96"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="7.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="11.89"
PriceToBookRatio="0.904"
EVToRevenue="1.156"
EVToEBITDA="-0.15"
Beta="1.338"
num_52WeekHigh="14.25"
num_52WeekLow="3.4"
num_50DayMovingAverage="5.15"
num_200DayMovingAverage="5.77"
SharesOutstanding="19601500"
DividendDate="None"
ExDividendDate="None"
symbol="SLDB"
open="3.85"
high="3.85"
low="3.70"
price="3.80"
volume="3115.00"
latest_trading_day="2023-08-11"
previous_close="3.81"
change="-0.01"
change_percent="-0.2625%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="58"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="42"
Volume_recent_avg="27308"
Change_recent_avg="0.01"
Delta_recent_avg="0.25"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="0.23"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="42"
Aroon_momentum_negative="58"
image_negative_thumbnail_id_1="123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0053.jpeg"
image_negative_thumbnail_id_2="111"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0065.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="682"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0026.jpeg"
image_positive_thumbnail_id_2="696"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0012.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
